Chadwick Harman
Geschäftsführer bei BLUE WATER VENTURES INTERNATIONAL, INC.
Aktive Positionen von Chadwick Harman
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Direktor/Vorstandsmitglied | - | - |
| Geschäftsführer | 12.12.2023 | - | |
| Vorstandsvorsitzender | - | 12.12.2023 | |
| Präsident | - | 12.12.2023 | |
Psycheceutical, Inc.
 Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Präsident | 12.12.2023 | - |
Karriereverlauf von Chadwick Harman
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| President | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sektoral
| Commercial Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BLUE WATER VENTURES INTERNATIONAL, INC. | Commercial Services |
| Private Unternehmen | 1 |
|---|---|
Psycheceutical, Inc.
Psycheceutical, Inc. Pharmaceuticals: MajorHealth Technology Psycheceutical, Inc. is a private company that aims to bring safety and efficacy to psychedelic compounds. The company is based in Fort Lauderdale, FL. The company has a team with over 100 years of combined experience in development, regulatory approval processes, and commercialization across the pharmaceutical industry. The company has next-generation patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds and provide direct and profound benefits to those suffering from mental disorders. Psycheceutical is removing barriers to care by employing state-of-the-art patented delivery technologies designed to increase the safety and efficacy of psychedelic compounds. Chad Harman has been the CEO of the company since 2021. | Health Technology |
- Börse
- Insiders
- Chadwick Harman
- Erfahrung
